Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine E Nelson

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014
Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTORRyan T Sowell, Magdalena Rogozinska, Christine E Nelson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2016
Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise LongevityEmily A Thompson, Lalit K Beura, Christine E Nelson, et al.
Mucosal Immunology|August 20, 2020
MAIT cell-directed therapy of Mycobacterium tuberculosis infectionShunsuke Sakai, Keith D Kauffman, Sangmi Oh, et al.
The Journal of Experimental Medicine|April 25, 2023
CD30 co-stimulation drives differentiation of protective T cells during Mycobacterium tuberculosis infectionTaylor W Foreman, Christine E Nelson, Michelle A Sallin, et al.
Cell Reports|September 19, 2019
Robust Iterative Stimulation with Self-Antigens Overcomes CD8<sup>+</sup> T Cell Tolerance to Self- and Tumor AntigensChristine E Nelson, Emily A Thompson, Clare F Quarnstrom, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2019
Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cellsChristine E Nelson, Lauren J Mills, Jennifer L McCurtain, et al.
Frontiers in Immunology|September 18, 2023
Co-infection of mice with SARS-CoV-2 and <i>Mycobacterium tuberculosis</i> limits early viral replication but does not affect mycobacterial loadsPaul J Baker, Eduardo P Amaral, Ehydel Castro, et al.
Nature Communications|February 6, 2019
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapyPamela C Rosato, Sathi Wijeyesinghe, J Michael Stolley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2015
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockadeKristen E Pauken, Christine E Nelson, Tijana Martinov, et al.
Plos One|March 10, 2026
Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primatesChristine E Nelson, Keith D Kauffman, Shunsuke Sakai, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014
Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTORRyan T Sowell, Magdalena Rogozinska, Christine E Nelson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2016
Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise LongevityEmily A Thompson, Lalit K Beura, Christine E Nelson, et al.
Mucosal Immunology|August 20, 2020
MAIT cell-directed therapy of Mycobacterium tuberculosis infectionShunsuke Sakai, Keith D Kauffman, Sangmi Oh, et al.
The Journal of Experimental Medicine|April 25, 2023
CD30 co-stimulation drives differentiation of protective T cells during Mycobacterium tuberculosis infectionTaylor W Foreman, Christine E Nelson, Michelle A Sallin, et al.
Cell Reports|September 19, 2019
Robust Iterative Stimulation with Self-Antigens Overcomes CD8<sup>+</sup> T Cell Tolerance to Self- and Tumor AntigensChristine E Nelson, Emily A Thompson, Clare F Quarnstrom, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2019
Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cellsChristine E Nelson, Lauren J Mills, Jennifer L McCurtain, et al.
Frontiers in Immunology|September 18, 2023
Co-infection of mice with SARS-CoV-2 and <i>Mycobacterium tuberculosis</i> limits early viral replication but does not affect mycobacterial loadsPaul J Baker, Eduardo P Amaral, Ehydel Castro, et al.
Nature Communications|February 6, 2019
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapyPamela C Rosato, Sathi Wijeyesinghe, J Michael Stolley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2015
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockadeKristen E Pauken, Christine E Nelson, Tijana Martinov, et al.
Plos One|March 10, 2026
Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primatesChristine E Nelson, Keith D Kauffman, Shunsuke Sakai, et al.
Pageof 3